HealthEquity, Inc. (NASDAQ:HQY) Holdings Decreased by Overbrook Management Corp

Overbrook Management Corp trimmed its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 5.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 69,416 shares of the company's stock after selling 3,867 shares during the quarter. HealthEquity makes up about 1.4% of Overbrook Management Corp's holdings, making the stock its 27th biggest position. Overbrook Management Corp owned 0.08% of HealthEquity worth $6,134,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of HQY. Transce3nd LLC purchased a new stake in shares of HealthEquity during the fourth quarter worth approximately $29,000. Versant Capital Management Inc purchased a new position in HealthEquity during the 1st quarter worth $28,000. Smartleaf Asset Management LLC lifted its stake in shares of HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after acquiring an additional 98 shares during the period. Skandinaviska Enskilda Banken AB publ boosted its holdings in shares of HealthEquity by 1,934.8% in the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock valued at $45,000 after acquiring an additional 445 shares in the last quarter. Finally, Lindbrook Capital LLC boosted its holdings in shares of HealthEquity by 27.6% in the fourth quarter. Lindbrook Capital LLC now owns 750 shares of the company's stock valued at $72,000 after acquiring an additional 162 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have commented on HQY shares. JMP Securities boosted their target price on shares of HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a research report on Wednesday, June 4th. Wall Street Zen raised shares of HealthEquity from a "hold" rating to a "buy" rating in a report on Friday, June 6th. Barrington Research upped their target price on shares of HealthEquity from $112.00 to $125.00 and gave the stock an "outperform" rating in a research report on Thursday, June 5th. KeyCorp dropped their target price on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a research note on Thursday, June 5th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, HealthEquity has an average rating of "Buy" and a consensus target price of $118.09.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 8,881 shares of the business's stock in a transaction dated Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the sale, the executive vice president owned 56,655 shares of the company's stock, valued at approximately $4,433,820.30. The trade was a 13.55% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction that occurred on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total value of $446,487.50. Following the transaction, the director directly owned 84,969 shares in the company, valued at $6,597,842.85. This trade represents a 6.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 304,581 shares of company stock valued at $33,664,018 over the last three months. Insiders own 1.50% of the company's stock.

HealthEquity Price Performance

HQY stock traded down $1.87 during trading on Tuesday, hitting $102.89. The stock had a trading volume of 921,212 shares, compared to its average volume of 1,041,759. The stock has a market cap of $8.90 billion, a price-to-earnings ratio of 75.10, a price-to-earnings-growth ratio of 1.61 and a beta of 0.49. The company has a debt-to-equity ratio of 0.50, a quick ratio of 4.06 and a current ratio of 4.06. The company's 50 day moving average price is $98.50 and its two-hundred day moving average price is $98.08. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $116.65.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.81 by $0.16. The business had revenue of $330.80 million for the quarter, compared to the consensus estimate of $322.25 million. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. During the same quarter in the prior year, the firm posted $0.80 earnings per share. On average, sell-side analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.